Androgen receptors protect against thoracic aortic dissection via inhibiting ferroptosis of vascular smooth muscle cells in male patients.
1/5 보강
[BACKGROUND] The development of thoracic aortic dissection (TAD) is closely associated with the loss of vascular smooth muscle cells (VSMCs).
APA
Ni Q, Wang Y, et al. (2025). Androgen receptors protect against thoracic aortic dissection via inhibiting ferroptosis of vascular smooth muscle cells in male patients.. Chinese medical journal. https://doi.org/10.1097/CM9.0000000000003749
MLA
Ni Q, et al.. "Androgen receptors protect against thoracic aortic dissection via inhibiting ferroptosis of vascular smooth muscle cells in male patients.." Chinese medical journal, 2025.
PMID
41098143 ↗
Abstract 한글 요약
[BACKGROUND] The development of thoracic aortic dissection (TAD) is closely associated with the loss of vascular smooth muscle cells (VSMCs). Androgen receptor (AR) signaling has increasingly been recognized as an important regulator of cell death in prostate cancer. However, the role of AR signaling in the development of TAD in men remains unknown.
[METHODS] The expression of AR was analyzed in clinical specimens obtained from TAD patients undergoing surgical aortic replacement and control subjects receiving heart transplantation. Using β-aminopropionitrile (BAPN)-induced aortic dissection mouse models, we systematically investigated the protective role of AR through multiple approaches. Histopathological evaluation was performed using immunohistochemistry and immunofluorescence. Primary vascular smooth muscle cells were isolated for functional studies including AR knockdown, ferroptosis assessment, and metabolic profiling. Mechanistic insights were gained through chromatin immunoprecipitation, luciferase reporter assays, and RNA stability tests. Seahorse extracellular flux analysis and targeted metabolomics were employed to characterize metabolic alterations.
[RESULTS] The expression of AR in VSMCs was downregulated in both clinical samples and animal models of TAD. Using in vitro and in vivo models, we demonstrate a novel function of AR that inhibits ferroptosis in VSMC by promoting excessive lipid peroxidation. Mechanistically, we show that AR counter-regulates the expression levels of acyl-CoA synthetases ACSL3 and ACSL4 in VSMCs. AR acts as a transcriptional regulator to promote the transcription of ACSL3 gene while inhibiting the transcription of the ACSL4 gene, both of which inhibit lipid peroxidation and ferroptosis. Importantly, activating AR signaling is beneficial in preventing TAD from developing and progressing in the animal model.
[CONCLUSIONS] Our results reveal a previously unrecognized role of AR in TAD pathogenesis and uncover the opposite yet complementary regulation of ACSL3/ACSL4 levels involved in lipid peroxidation-driven ferroptosis in VSMCs.
[METHODS] The expression of AR was analyzed in clinical specimens obtained from TAD patients undergoing surgical aortic replacement and control subjects receiving heart transplantation. Using β-aminopropionitrile (BAPN)-induced aortic dissection mouse models, we systematically investigated the protective role of AR through multiple approaches. Histopathological evaluation was performed using immunohistochemistry and immunofluorescence. Primary vascular smooth muscle cells were isolated for functional studies including AR knockdown, ferroptosis assessment, and metabolic profiling. Mechanistic insights were gained through chromatin immunoprecipitation, luciferase reporter assays, and RNA stability tests. Seahorse extracellular flux analysis and targeted metabolomics were employed to characterize metabolic alterations.
[RESULTS] The expression of AR in VSMCs was downregulated in both clinical samples and animal models of TAD. Using in vitro and in vivo models, we demonstrate a novel function of AR that inhibits ferroptosis in VSMC by promoting excessive lipid peroxidation. Mechanistically, we show that AR counter-regulates the expression levels of acyl-CoA synthetases ACSL3 and ACSL4 in VSMCs. AR acts as a transcriptional regulator to promote the transcription of ACSL3 gene while inhibiting the transcription of the ACSL4 gene, both of which inhibit lipid peroxidation and ferroptosis. Importantly, activating AR signaling is beneficial in preventing TAD from developing and progressing in the animal model.
[CONCLUSIONS] Our results reveal a previously unrecognized role of AR in TAD pathogenesis and uncover the opposite yet complementary regulation of ACSL3/ACSL4 levels involved in lipid peroxidation-driven ferroptosis in VSMCs.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (3)
- VSIG2 hinders gastric cancer progression by suppressing ANXA2-mediated NF-κB pathway activation.
- Single-cell transcriptomic data reveal the cellular heterogeneity of glutamine metabolism in gastric premalignant lesions and early gastric cancer.
- The role of the C5a-C5aR pathway in iron metabolism and gastric cancer progression.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- Therapy-induced androgen receptor signaling as a candidate upstream driver of B7-H3-linked immune exclusion in melanoma: mechanisms and translational opportunities.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Identifying sorafenib benefit among patients with hepatocellular carcinoma: A transcriptomic and genomic approach.
- Decoding the Anti-Tumour Mechanism of ɑ-Solanine: SRC Inhibition and Ferroptosis Induction in Colon Cancer.
- Apatinib and silver nanoparticles synergize against gastric cancer through the PI3K/Akt signaling pathway-mediated ferroptosis.
- Preclinical and first-in-human evaluation of novel androgen receptor-targeted PET imaging in prostate cancer.